Treatment as Prevention for Hepatitis C in Iceland

Recruiting now

Conditions studied: Hepatitis C

In brief

The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.

Key facts

Study ID

NCT02647879

Run by

Landspitali University Hospital

People needed

1000

Starts

2016-01-01

Expected to finish

2031-05-01

Last updated by the study team

2020-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.

You may not qualify if…

• Age under 18 years
• Inability to sign informed consent.

Where it is running

• Landspitali — Reykjavik, Iceland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.